07:00 , Aug 1, 2011 |  BC Week In Review  |  Clinical News

Ambulight PDT regulatory update

The U.K.'s NICE issued final guidance concluding that the case for adopting Ambicare's Ambulight photodynamic therapy (PDT) to treat non-melanoma skin cancer over current management could not be supported and would remain as a treatment...
08:00 , Jan 10, 2011 |  BC Week In Review  |  Clinical News

Ambulight PDT regulatory update

The U.K.'s NICE issued draft guidance concluding that the case for adopting Ambicare's Ambulight photodynamic therapy (PDT) to treat non-melanoma skin cancer over current management could not be supported and would remain as a treatment...